explore -WSS

explore

author：comprehensive 2025-10-02 22:56:34 - browse：4585

Colorful illustration of scientists using computers and Artificial Intelligence technology to visualize proteins for drug development – biotech coverage from STAT — Mike Reddy for STAT

David Reese calls it a “hinge moment” — the turning point when biotech and big tech merge to attack human disease with artificial intelligence.

At Amgen, where he’s led drug research and development since 2018, Reese said this moment has finally arrived. The proof lies not only in organizational changes, such as his recent appointment as the company’s first chief technology officer, but also in Amgen’s broader push to embed AI into every aspect of the drug discovery process.

“We’re now seeing 10-fold improvements in these (AI) models every six months,” said Reese, a medical oncologist by training. He added that the quickening pace of advancement means investing in the technology is no longer optional: “It’s something we must do to have a practical, pragmatic impact on drug discovery.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： FTC sues over Novant Health acquisition of two N.C. hospitals

explore

WSS

Woodcock on FDA’s accelerated approval and her next chapter

FTC sues over Novant Health acquisition of two N.C. hospitals

Apple Vision Pro: A first look at health apps on the new VR headset

The real point of Kenneth Smith’s execution by nitrogen gas

The real point of Kenneth Smith’s execution by nitrogen gas

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

leisure time

explore

focus

Drug repurposing or repositioning? The language matters

Do digital therapeutics have a future in medicine?

Psychedelics group wrestles with new pharma identity

Bernie Sanders is gearing up to subpoena pharma CEOs

Trump demands the U.S. pay no more for drugs than other countries … again

Vertex non

Bright Health sells Medicare Advantage business to Molina

Even great ERs can’t make up for American health disparities

Tori Bowie and the unacceptable rates of Black maternal death

Cybersecurity threat forces Lurie Children's to take systems offline

explore

Vertex non

Investment in vaccine development is lagging, report finds

FTC sues over Novant Health acquisition of two N.C. hospitals

The lessons of Aduhelm, an Alzheimer's drug that was not to be

White House pharmacy plagued with problems, investigation finds

White House pharmacy plagued with problems, investigation finds

entertainment

leisure time

explore

knowledge